{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:01:47Z","timestamp":1779321707400,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.thromres.2017.05.013","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T06:47:15Z","timestamp":1494658035000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Platelets and hemophilia: A review of the literature"],"prefix":"10.1016","volume":"155","author":[{"given":"Julia","family":"Riedl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10040","key":"10.1016\/j.thromres.2017.05.013_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(15)01123-X","article-title":"The past and future of haemophilia: diagnosis, treatments, and its complications","volume":"388","author":"Peyvandi","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.thromres.2017.05.013_bb0010","first-page":"314","article-title":"Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future","volume":"12","author":"Jim\u00e9nez-Yuste","year":"2014","journal-title":"Blood Transfus. Trasfus. Sangue."},{"key":"10.1016\/j.thromres.2017.05.013_bb0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-0033-1354426","article-title":"Defining severity of hemophilia: more than factor levels","volume":"39","author":"Pavlova","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2017.05.013_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2008-1066024","article-title":"The phenotypic heterogeneity of severe hemophilia","volume":"34","author":"Jayandharan","year":"2008","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2017.05.013_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bjh.13423","article-title":"A cross-sectional study of bleeding phenotype in haemophilia A carriers","volume":"170","author":"Paroskie","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2017.05.013_bb0030","first-page":"722","article-title":"Platelet coagulant activities and clinical severity in haemophilia","volume":"29","author":"Walsh","year":"1973","journal-title":"Thromb. Diath. Haemorrh."},{"key":"10.1016\/j.thromres.2017.05.013_bb0035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1100\/tsw.2006.133","article-title":"Platelets as modifiers of clinical phenotype in hemophilia","volume":"6","author":"Yee","year":"2006","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.thromres.2017.05.013_bb0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.12045","article-title":"Platelet-based coagulation: different populations, different functions","volume":"11","author":"Heemskerk","year":"2013","journal-title":"J. Thromb. Haemost. JTH."},{"key":"10.1016\/j.thromres.2017.05.013_bb0045","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell-based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.013_bb0050","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3324\/haematol.2014.116863","article-title":"Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow","volume":"100","author":"Swieringa","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2017.05.013_bb0055","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2017.05.013_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1096-7192(03)00049-0","article-title":"Expression of human factor VIII under control of the platelet-specific \u03b1IIb promoter in megakaryocytic cell line as well as storage together with VWF","volume":"79","author":"Shi","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.thromres.2017.05.013_bb0065","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1182\/blood-2003-05-1519","article-title":"Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment","volume":"102","author":"Yarovoi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.05.013_bb0070","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.2014.123117","article-title":"Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A","volume":"100","author":"Zanolini","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2017.05.013_bb0075","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3324\/haematol.2015.129858","article-title":"The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A","volume":"100","author":"Arruda","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2017.05.013_bb0080","doi-asserted-by":"crossref","first-page":"16467","DOI":"10.1016\/S0021-9258(18)37615-4","article-title":"The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets","volume":"263","author":"Nesheim","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2017.05.013_bb0085","doi-asserted-by":"crossref","first-page":"13071","DOI":"10.1074\/jbc.275.17.13071","article-title":"Structural and functional characterization of platelet receptor-mediated factor VIII binding","volume":"275","author":"Ahmad","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2017.05.013_bb0090","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1538-7836.2008.03010.x","article-title":"Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure","volume":"6","author":"Shi","year":"2008","journal-title":"J. Thromb. Haemost. JTH."},{"key":"10.1016\/j.thromres.2017.05.013_bb0095","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2015-01-620245","article-title":"Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine","volume":"126","author":"Gilbert","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.05.013_bb0100","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood-2015-07-657924","article-title":"fVIII binds platelets+fibrin: no PS!","volume":"126","author":"Pratt","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.05.013_bb0105","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1172\/JCI114242","article-title":"Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome","volume":"84","author":"Ahmad","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2017.05.013_bb0110","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/nm899","article-title":"Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A","volume":"9","author":"Hrachovinov\u00e1","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.thromres.2017.05.013_bb0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/09537100600747035","article-title":"Factor VIII is a positive regulator of platelet function","volume":"17","author":"Obergfell","year":"2006","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2017.05.013_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3324\/haematol.2015.133462","article-title":"Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A","volume":"101","author":"Melchiorre","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2017.05.013_bb0125","first-page":"1","article-title":"Haemophilia B is clinically less severe than haemophilia A: further evidence","author":"Franchini","year":"2016","journal-title":"Blood Transfus. Trasfus. Sangue."},{"key":"10.1016\/j.thromres.2017.05.013_bb0130","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1160\/TH13-07-0546","article-title":"Platelet degranulation and glycoprotein IIbIIIa opening are not related to bleeding phenotype in severe haemophilia A patients","volume":"111","author":"van Bladel","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.013_bb0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ajh.10057","article-title":"Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C)","volume":"69","author":"Freedman","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2017.05.013_bb0140","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1910.04330140029009","article-title":"The relation of blood platelets to hemorrhagic disease: description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion","volume":"55","author":"DUKE","year":"1910","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.thromres.2017.05.013_bb0145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V58.4.719.719","article-title":"The bleeding time is longer than normal in hemophilia","volume":"58","author":"Eyster","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.05.013_bb0150","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1542\/peds.66.6.951","article-title":"Prolonged bleeding time in children and young adults with hemophilia","volume":"66","author":"Buchanan","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2017.05.013_bb0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ajcp\/83.2.211","article-title":"The prolonged bleeding time in hemophilia A: comparison of two measuring technics and clinical associations","volume":"83","author":"Smith","year":"1985","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.thromres.2017.05.013_bb0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ajcp\/84.2.259","volume":"84","year":"1985","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.thromres.2017.05.013_bb0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3476(86)80985-4","article-title":"Bleeding time in hemophilia A: potential mechanisms for prolongation","volume":"108","author":"Stuart","year":"1986","journal-title":"J. Pediatr."},{"key":"10.1016\/j.thromres.2017.05.013_bb0170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2141.1998.00656.x","article-title":"The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children","volume":"101","author":"Carcao","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2017.05.013_bb0175","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2516.2011.02601.x","article-title":"Platelets significantly modify procoagulant activities in haemophilia A","volume":"17","author":"Wartiovaara-Kautto","year":"2011","journal-title":"Haemoph. Off. J. World Fed. Hemoph."},{"key":"10.1016\/j.thromres.2017.05.013_bb0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/0953710021000059422","article-title":"Absence of compensatory platelet activation in patients with severe haemophilia, but evidence for a platelet collagen-activation defect","volume":"13","author":"Gr\u00fcnewald","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2017.05.013_bb0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MBC.0b013e32832da1ad","article-title":"Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease","volume":"20","author":"Favaloro","year":"2009","journal-title":"Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb."},{"key":"10.1016\/j.thromres.2017.05.013_bb0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0038-1651119","article-title":"Platelet release in hemophilia","volume":"57","author":"Al-Mondhiry","year":"1987","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.013_bb0195","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2011.042663","article-title":"Up-regulation of platelet activation in hemophilia A","volume":"96","author":"van Bladel","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2017.05.013_bb0200","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3324\/haematol.2012.065235","article-title":"Activation state of platelets in experimental severe hemophilia A","volume":"97","author":"Teyssandier","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2017.05.013_bb0205","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1182\/blood.V124.21.4994.4994","article-title":"No association between platelet function and hemophilia B phenotype","volume":"124","author":"Schutgens","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.05.013_bb0210","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/ATVBAHA.113.301790","article-title":"Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets","volume":"33","author":"Mazepa","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2017.05.013_bb0215","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1538-7836.2010.03828.x","article-title":"Coated-platelet levels may explain some variability in clinical phenotypes observed with severe hemophilia","volume":"8","author":"Saxena","year":"2010","journal-title":"J. Thromb. Haemost. JTH."},{"key":"10.1016\/j.thromres.2017.05.013_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/hae.12844","article-title":"Coated platelets and severe haemophilia A bleeding phenotype: is there a connection?","volume":"22","author":"Lastrapes","year":"2016","journal-title":"Haemoph. Off. J. World Fed. Hemoph."},{"key":"10.1016\/j.thromres.2017.05.013_bb0225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1538-7836.2003.00021.x","article-title":"Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies","volume":"1","author":"Carr","year":"2003","journal-title":"J. Thromb. Haemost. JTH."},{"key":"10.1016\/j.thromres.2017.05.013_bb0230","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/hae.12099","article-title":"Platelet activation and aggregation: the importance of thrombin activity\u2014a laboratory model","volume":"19","author":"Jensen","year":"2013","journal-title":"Haemoph. Off. J. World Fed. Hemoph."},{"key":"10.1016\/j.thromres.2017.05.013_bb0235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jth.12457","article-title":"Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels","volume":"12","author":"Colace","year":"2014","journal-title":"J. Thromb. Haemost. JTH."},{"key":"10.1016\/j.thromres.2017.05.013_bb0240","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/09537100600757448","article-title":"Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A","volume":"17","author":"Bassus","year":"2006","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2017.05.013_bb0245","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1160\/TH03-01-0027","article-title":"Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma","volume":"90","author":"Siegemund","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.013_bb0250","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1038\/ncomms3773","article-title":"Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A","volume":"4","author":"Du","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.thromres.2017.05.013_bb0255","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/jth.13169","article-title":"Comparison of platelet-derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay","volume":"13","author":"Baumgartner","year":"2015","journal-title":"J. Thromb. Haemost. JTH."},{"key":"10.1016\/j.thromres.2017.05.013_bb0260","article-title":"Targeting Factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice","author":"Baumgartner","year":"2016","journal-title":"J. Thromb. Haemost. JTH."},{"key":"10.1016\/j.thromres.2017.05.013_bb0265","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2009-11-255612","article-title":"Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2017.05.013_bb0270","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1111\/jth.12938","article-title":"Platelet-delivered therapeutics","volume":"13","author":"Lyde","year":"2015","journal-title":"J. Thromb. Haemost. JTH."},{"key":"10.1016\/j.thromres.2017.05.013_bb0275","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2015-08-662916","article-title":"The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity","volume":"127","author":"Chen","year":"2016","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T03:19:46Z","timestamp":1719199186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384817303286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":55,"alternative-id":["S0049384817303286"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.013","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelets and hemophilia: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}